Provider Review · Updated November 2026
Hers Weight Loss Review 2026: What Changed and What It Costs
Hers is the women-facing brand of Hims & Hers Health. Until early 2026 its weight loss program centered on compounded semaglutide. In March 2026 the company [announced a strategic shift](https://www.sec.gov/Archives/edgar/data/1773751/000177375126000033/ex991pressrelease.htm): brand-name Wegovy and Ozempic through a Novo Nordisk collaboration, and compounded GLP-1s only for a limited set of patients whose provider finds them clinically necessary. Here is what we could verify on Nov 4, 2026.
Quick Facts
| Detail | Hers |
|---|---|
| Company | Hims & Hers Health, Inc. (NYSE: HIMS) |
| Medications announced | Wegovy pills and injections, Ozempic injections (Novo Nordisk collaboration, March 2026) |
| Compounded GLP-1s | Limited scale, only when a provider determines it is clinically necessary |
| Pharmacies for compounded GLP-1s | 503A compounding pharmacies only, per the company |
| Pricing | Not confirmed. forhers.com blocked automated checks on Nov 4, 2026 |
| Membership | The company says it launched a weight loss membership program in 2026 |
What Is Hers?
Hers is the women’s counterpart to Hims. Both brands belong to Hims & Hers Health, a publicly traded company listed on the New York Stock Exchange under HIMS.
The March 9, 2026 press release says the company “will no longer advertise compounded GLP-1 offerings on its platform or in its marketing.” It lists the Novo Nordisk products coming to the platform: Ozempic 0.5 mg, 1 mg and 2 mg injections, Wegovy 1.7 mg or 2.4 mg injections, and Wegovy 1.5 mg, 4 mg, 9 mg and 25 mg tablets. Existing patients could transition to FDA-approved medicines when their providers judged it clinically appropriate.
The company’s quarterly report for the period ending June 30, 2026 confirms the shift and adds that “we launched a membership program for our weight loss offerings.”
Semaglutide is the active ingredient in Wegovy and Ozempic. In the STEP 1 trial, weekly semaglutide 2.4 mg produced a mean weight change of -14.9% at 68 weeks versus -2.4% with placebo. In STEP 5, published in Nature Medicine in 2022, the mean change at 104 weeks was -15.2% with semaglutide versus -2.6% with placebo.
Hers markets its program to women, and hormonal factors such as PCOS and perimenopause can affect weight. Our best GLP-1 for women guide covers those topics.
Pricing: What It Actually Costs
We could not load forhers.com on Nov 4, 2026 because the site blocked automated access. We are not listing a Hers price we could not confirm. Check the price on the Hers site during signup, and ask whether a membership fee is billed separately from medication.
For brand-name reference, here are the NovoCare self-pay prices for Wegovy as of Nov 4, 2026:
| Wegovy option | NovoCare self-pay price |
|---|---|
| Pill, 1.5 mg | $149/month |
| Pill, 4 mg | $199/month |
| Pill, 9 mg and 25 mg | $299/month |
| Pen, new patients | $199/month for the first 2 months |
| Pen, 0.25 mg to 2.4 mg after intro | $349/month |
| Wegovy HD 7.2 mg pen | $399/month |
NovoCare says these prices apply through December 31, 2026 and may change. A telehealth membership, if any, would be on top of the medication cost.
If your insurance covers Wegovy or Zepbound, your copay may be lower than these prices. The GLP-1 cash pay vs insurance guide and the FSA/HSA for GLP-1 medications guide are worth reading before you decide.
See Hers's current pricing and programs
View Hers Profile →How It Works
- Complete the online intake. Questions cover weight, health history, medications and goals.
- Provider review. Hims & Hers says customers reach licensed providers through video, phone, or store-and-forward (asynchronous) consultations.
- Prescription. If appropriate, the provider prescribes a brand-name GLP-1, or in limited cases a compounded product.
- Ongoing care. The March 2026 release says the company continues to offer direct access to providers, nutrition guidance and clinical check-ins.
I’ve tracked my own progression on Mounjaro (tirzepatide) using DEXA scans every six months. Clear titration guidance matters early in any GLP-1 program, because the urge to push doses too fast is real. Follow your prescriber’s schedule. If you want to understand body composition beyond scale weight, the GLP-1 body composition guide covers what to measure.
Safety Notes
The Wegovy label carries a boxed warning for thyroid C-cell tumors. Do not use it if you or a family member has had medullary thyroid cancer or MEN 2. The label also warns about acute pancreatitis, and says to stop Wegovy at least 2 months before a planned pregnancy because of semaglutide’s long half-life. Tell your prescriber about kidney problems, gallbladder disease, or any pancreatitis history.
Who Is Hers Best For?
Possible fit:
- Women who want brand-name Wegovy or Ozempic through a large telehealth platform
- People who prefer asynchronous messaging over scheduled visits
- People paying cash who want a single app for prescribing and follow-up
Not the best fit:
- Anyone who specifically wants compounded semaglutide. Hers now offers it only in limited cases.
- People who want tirzepatide (Zepbound or Mounjaro). The March 2026 announcement listed Novo Nordisk products only.
- Men. The equivalent brand is Hims Weight Loss.
If hormonal weight gain is part of your picture, see the best GLP-1 for women guide. For fat loss versus scale weight, see the fat loss vs weight loss on GLP-1s guide.
Pros and Cons
Pros:
- Access to brand-name Wegovy (pill and pen) and Ozempic announced through a Novo Nordisk collaboration
- Backed by a publicly traded company
- Provider access by video, phone or asynchronous messaging
Cons:
- We could not confirm current prices on Nov 4, 2026
- Compounded semaglutide now limited to cases a provider deems clinically necessary
- Regulatory history: named in a February 2026 FDA statement and referred by HHS to the DOJ, per the company
- No tirzepatide products named in the March 2026 announcement
How Hers Compares
Hers vs Hims
Both brands run on the same company platform and made the same March 2026 shift to brand-name GLP-1s. If you’re a woman, Hers is the brand aimed at you. If you’re a man, see Hims.
Hers vs Ro
Ro focuses on brand-name GLP-1s with insurance help. If your insurance covers a brand-name GLP-1, a platform with insurance navigation may cost less after copay.
Hers vs Noom Med
Noom Med combines medication with behavior change coaching. If you want structured coaching alongside medication, it is worth comparing.
Regulatory Background
The FDA’s February 6, 2026 statement announced its intent to restrict GLP-1 ingredients used in non-FDA-approved compounded drugs that are mass-marketed, and named Hims & Hers. The company’s quarterly report says HHS referred it to the DOJ for investigation that month. The report also says Novo Nordisk sued Hims & Hers for patent infringement on February 9, 2026, and the March 2026 release says Novo Nordisk was dismissing that suit without prejudice as part of the new collaboration.
The Bottom Line
Hers is no longer the compounded semaglutide program this page used to describe. It now leads with brand-name Wegovy and Ozempic. That brings FDA-approved medication and NovoCare-level pricing into play, plus whatever membership Hers charges on top. Confirm the total monthly cost on the Hers site before you sign up, and compare it with buying Wegovy directly through NovoCare.
For comparison shopping across providers, the best online GLP-1 programs page shows where Hers sits relative to the field.
Ready to explore Hers?
Check Hers Prices →FAQ
Is Hers weight loss only for women?
Hers is the women-facing brand of Hims & Hers Health. The equivalent brand for men is Hims, which runs on the same company platform.
What medication does Hers prescribe for weight loss?
In March 2026, Hims & Hers announced it would bring Ozempic injections and Wegovy pills and injections to its platform through a collaboration with Novo Nordisk. It also said it would stop advertising compounded GLP-1s and offer them only when a provider finds a compounded product clinically necessary. A provider decides which, if any, medication fits you.
How much does Hers cost?
forhers.com blocked our automated checks on Nov 4, 2026, so we could not confirm current Hers prices. Hims & Hers says it launched a weight loss membership program in 2026. For brand-name reference, NovoCare self-pay pricing for Wegovy was $149 to $299 a month for the pill and $349 a month for most pen doses after a $199 intro offer, as of Nov 4, 2026.
Does Hers accept insurance for its weight loss program?
We could not confirm Hers’ insurance policy on Nov 4, 2026. Check during signup, and if you have commercial coverage, compare your copay with the self-pay price.
Is compounded semaglutide from Hers safe and legal?
Compounded drugs are not FDA-approved. Hims & Hers says it uses only 503A compounding pharmacies for compounded GLP-1s. In February 2026, the FDA named Hims & Hers in a statement about restricting GLP-1 ingredients for mass-marketed compounded drugs, and the company said HHS referred it to the DOJ for investigation. See our compounded semaglutide legal 2026 guide.
Related
Guides:
- Best GLP-1 for Women: Hormones, PCOS, and Menopause
- Cheapest GLP-1 Online
- FSA/HSA for GLP-1 Medications
- Compounded vs Brand-Name GLP-1
- Is Compounded Semaglutide Still Legal in 2026?
Provider Reviews:
Compare: All Providers | Best GLP-1 Programs | Compounded Semaglutide: Cost and Providers
What we checked
This AI-assisted public-source desk check reviewed the Hims & Hers March 2026 press release and June 2026 quarterly report on SEC EDGAR, the FDA’s February 2026 statement, NovoCare’s Wegovy self-pay pricing, the Wegovy prescribing information and the STEP 1 and STEP 5 trial abstracts on November 4, 2026. forhers.com blocked automated access, so we could not confirm Hers prices. We did not complete signup, pay for treatment, test delivery or support, or independently verify clinician and pharmacy credentials. Prices and policies change, so confirm them with the provider or your prescriber before you act.